Influenza virus infections pose a significant threat to public health due to annual seasonal
epidemics and occasional pandemics. Influenza is also associated with significant economic …

Immunocompromised persons are at high risk of complications from influenza infection. This
population includes those with solid organ transplants, hematopoietic stem cell transplants …

The unprecedented speed of delivery of SARS-CoV-2 pandemic vaccines has redefined the
limits for all vaccine development. Beyond the aspirational 100-day timeline for tomorrow's …

Influenza A viruses (IAV) can infect a broad range of animal hosts, including humans. In
humans, IAV causes seasonal annual epidemics and occasional pandemics, representing a …

This systematic review assesses the literature for estimates of influenza vaccine
effectiveness (IVE) against laboratory-confirmed influenza-associated hospitalization in …

Influenza virus still represents a considerable threat to global public health, despite the
advances in the development and wide use of influenza vaccines. Vaccination with …

Background Influenza infection is a highly preventable transmissible viral disease
associated with mild upper respiratory symptoms and more severe conditions such as lethal …

BACKGROUND: Researchers in observational studies of vaccine effectiveness (VE) in
which they compared quadrivalent live attenuated vaccine (LAIV4) and inactivated influenza …

Introduction The United Kingdom is in the fourth season of introducing a universal childhood
influenza vaccine programme. The 2016/17 season saw early influenza A (H3N2) virus …

The USA has a long-standing paediatric influenza vaccination programme, including use of
live attenuated influenza vaccine (LAIV). Following US evidence of apparent lack of vaccine …